WallStreetZenWallStreetZen

NASDAQ: MEIP
Mei Pharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MEIP

Based on 1 analyst offering 12 month price targets for Mei Pharma Inc.
Min Forecast
$7.00+125.81%
Avg Forecast
$7.00+125.81%
Max Forecast
$7.00+125.81%

Should I buy or sell MEIP stock?

Based on 1 analyst offering ratings for Mei Pharma Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MEIP stock forecasts and price targets.

MEIP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-12

1 of 1

Forecast return on equity

Is MEIP forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is MEIP forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

MEIP revenue forecast

What is MEIP's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$65.5M-9.88%
Avg 2 year Forecast
$12.5M-82.79%
Avg 3 year Forecast
$25.0M-65.59%
MEIP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MEIP revenue growth forecast

How is MEIP forecast to perform vs Biotechnology companies and vs the US market?
Company
-42.12%
Industry
37.04%
Market
9.92%
MEIP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MEIP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MEIP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MEIP$3.10$7.00+125.81%Hold
CERO$1.41N/AN/A
RNXT$1.21$4.00+230.58%Strong Buy
AIM$0.41N/AN/A
SYBX$1.86$15.50+733.33%Buy
View Top Biotech Stocks

Mei Pharma Stock Forecast FAQ

Is Mei Pharma Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: MEIP) stock is to Hold MEIP stock.

Out of 1 analyst, 0 (0%) are recommending MEIP as a Strong Buy, 0 (0%) are recommending MEIP as a Buy, 1 (100%) are recommending MEIP as a Hold, 0 (0%) are recommending MEIP as a Sell, and 0 (0%) are recommending MEIP as a Strong Sell.

If you're new to stock investing, here's how to buy Mei Pharma stock.

What is MEIP's revenue growth forecast for 2024-2026?

(NASDAQ: MEIP) Mei Pharma's forecast annual revenue growth rate of -42.12% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Mei Pharma's revenue in 2024 is $72,648,000.On average, 1 Wall Street analysts forecast MEIP's revenue for 2024 to be $436,217,248, with the lowest MEIP revenue forecast at $436,217,248, and the highest MEIP revenue forecast at $436,217,248. On average, 1 Wall Street analysts forecast MEIP's revenue for 2025 to be $83,285,713, with the lowest MEIP revenue forecast at $83,285,713, and the highest MEIP revenue forecast at $83,285,713.

In 2026, MEIP is forecast to generate $166,571,425 in revenue, with the lowest revenue forecast at $166,571,425 and the highest revenue forecast at $166,571,425.

What is MEIP's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: MEIP) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is MEIP's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MEIP price target, the average MEIP price target is $7.00, with the highest MEIP stock price forecast at $7.00 and the lowest MEIP stock price forecast at $7.00.

The Wall Street analyst predicted that Mei Pharma's share price could reach $7.00 by Apr 12, 2025. The average Mei Pharma stock price prediction forecasts a potential upside of 125.81% from the current MEIP share price of $3.10.

What is MEIP's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: MEIP) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.